<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05012228</url>
  </required_header>
  <id_info>
    <org_study_id>202101074RINC</org_study_id>
    <nct_id>NCT05012228</nct_id>
  </id_info>
  <brief_title>Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome</brief_title>
  <official_title>Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is to understand the LTBP4 expression in human renal fibrotic tissues. The&#xD;
      investigators will exam major location of LTBP4 expression and check any similar or&#xD;
      discrepancy in renal fibrosis with different etiologies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will obtain the residual renal tissues with different etiologies and check&#xD;
      the expression of LTBP4. The location and quantitation of LTBP4 in renal tissues will be&#xD;
      checked. It will be great to understand the association between the severity of fibrosis and&#xD;
      the expression of LTBP4 and other matrix proteins.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Expression of LTBP4 in human renal fibrotic tissue</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Expression of biomarkers in human renal fibrotic tissue</measure>
    <time_frame>5 years</time_frame>
    <description>Potential markers: eg. ROS-related proteins (8-oxodG, 4-HNE)</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Renal Fibrosis, CKD</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with chronic kidney disease, which has remaining specimens in NTUH. The&#xD;
        investigators want to use 2008-2016 specimens in Department of Pathology, NTUH.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Abnormal kidney function, proteinuria, hematuria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  N/A&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chi-Ting Su, MD, MPH, PhD</last_name>
    <phone>+88697262878</phone>
    <email>A01218@ntucc.gov.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yue-Jhu Huang, MS</last_name>
    <phone>+886912282113</phone>
    <email>yuejhuhuang@outlook.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chi-Ting Su, MD. MPH. PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 3, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>LTBP4</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

